Rate My Professor Timothy Mercer

Mercer's research specializes in genomics, transcriptomics, synthetic biology, and RNA regulation of the genome, with a focus on the expression and splicing of synthetic genes, bioinformatics, and genome biotechnologies such as mRNA production and quality analysis. During his PhD under Professor John Mattick at the Institute for Molecular Bioscience, he helped identify tens of thousands of new non-coding RNA genes and contributed to capture sequencing techniques that are now standard first-line diagnostics for fusion genes in cancer. His highly influential publications include 'Integrative analysis of 111 reference human epigenomes' (Nature, 2015, over 7,000 citations), 'Long non-coding RNAs: insights into functions' (Nature Reviews Genetics, 2009, over 6,600 citations), 'Long non-coding RNAs: definitions, functions, challenges and recommendations' (Nature Reviews Molecular Cell Biology, 2023), 'The role of testing during the COVID-19 pandemic' (Nature Reviews Genetics, 2021), and recent works on mRNA vaccine quality using RNA sequencing (Nature Communications, 2023) and rapid expression of therapeutic antibodies via mRNA transfection (mAbs, 2026). With more than 36,000 citations on Google Scholar, Mercer's contributions have advanced precision oncology, epigenetic regulation, and mRNA therapies.